Skip to main content

1-8 of 8 results for subject:Pfizer

Subject X
Competition

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

More
Competition (8)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

(2) if he will refer the proposal by Pfizer to sell its products through a single distribution channel from early 2007 to the Office of Fair Trading for review; and if he will make a statement.

Asked by
Nick Hurd (Conservative)
Answering body
Department of Trade and Industry
Type
Written questions
Status
Answered
Date
30 November 2006
Reference
103303; 453 c824W
House
House of Commons

To ask the Secretary of State for Trade and Industry (1) what assessment his Department has made of the potential impact on (a) concurrent choice and (b) competition of the decision by Pfizer to sell its products through a single distribution channel;

Asked by
Nick Hurd (Conservative)
Answering body
Department of Trade and Industry
Type
Written questions
Status
Answered
Date
30 November 2006
Reference
103302; 453 c824W
House
House of Commons

My right hon. Friend will no doubt be aware of early-day motion 2786, which refers to the recent deal between Pfizer and Unichem. [That this House expresses deep concern over the decision by Pfizer to award the contract for sole supplying of its pharmaceutical products to one wholesaler Unichem; is...

Member
Jim McGovern (Labour)
Type
Proceeding contributions
Date
26 October 2006
Reference
450 c1692
House
House of Commons

Yes, I understand the concern that my hon. Friend raises. I hope he is able to get a slot for an Adjournment debate or a debate in Westminster Hall. I will pass on his concerns not only to our right hon. Friend the Secretary of State for Health, but to...

Member
Jack Straw (Labour)
Type
Proceeding contributions
Date
26 October 2006
Reference
450 c1692-3
House
House of Commons
Answered by
Baroness Beckett (Labour)
Answering body
Department of Trade and Industry
Type
Oral answers to questions
Date
14 May 1998
Reference
312 c511-2;312 c513-4
House
House of Commons
1st supplementary on effect of staff investment on competitiveness and success of Pfizer.
Asked by
Stephen Ladyman (Labour)
Answering body
Department of Trade and Industry
Oral questions - 1st Supplementary
Status
Answered
Date
14 May 1998
Reference
312 c511-2;312 c513-4
House
House of Commons
To comment on the progress of her Competitiveness UK initiative. -
Asked by
Stephen Ladyman (Labour)
Answering body
Department of Trade and Industry
Oral questions - Lead
Status
Answered
Date
14 May 1998
Reference
312 c511-2;312 c513-4; 40966
House
House of Commons
Answered by
Baroness Beckett (Labour)
Answering body
Department of Trade and Industry
Type
Oral answers to questions
Date
14 May 1998
Reference
312 c511-2;312 c513-4
House
House of Commons